InvestorsHub Logo
Followers 53
Posts 1782
Boards Moderated 0
Alias Born 03/22/2015

Re: Dante Fantasia post# 285257

Tuesday, 03/06/2018 7:37:40 PM

Tuesday, March 06, 2018 7:37:40 PM

Post# of 402169

No new patent on the new formulation? I am surprised they don't have one if it really is that good...though would suspect that because they have been able to keep it to themselves, no need to disclose at this point, so that may not be an issue at all. Still, I would have still expected to see a patent at this point to ensure ownership exclusivity.







https://seekingalpha.com/article/4145826-elite-pharmaceuticals-eltp-ceo-nasrat-hakim-q3-2018-results-earnings-call-transcript?part=single


Can you share any details on the unique abuse deterrent formulations without SequestOx’s of Naltrexone that was included in the pilot study?

No, except to say, I am extremely excited about this formulation because it also is a platform that apply to all the IRs and it happened to be about maybe 10% of the cost. So we're extremely excited about this, but it's still too early in the next few months. Once Dr. Smith files a patent and we do a little more trials, we’ll update a little more about it.






Call on God but row away from the rocks.

-Hunter S. Thompson

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News